Investor Relations
home » Investor Relations » Investor Relations Home

Investor Relations Home

Corporate Profile

Inovio Pharmaceuticals (NYSE Amex: INO) is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines. A comprehensive description of Inovio, its product pipeline, and its leading More >>

 

Stock Quote
Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Inovio Pharmaceuticals posts new information to the site. Just enter your e-mail address and click Submit.

 


Print Email RSS